MAPT and Alzheimer disease: Here, we exposed AD and NDAN BDTOs to 0.5, 1, and 2.5 μg/mL of PK for 1 hour and evaluated their proteolytic patterns by WB probed with Tau 5 and Tau 13 antibodies (Figure 4).